Analysis: Large pharma companies do little new drug innovation
Among their top-selling drugs, 76% of Pfizer's and 89% of J&J's were developed by other companies and account for nearly 90% of revenues.
Continue Reading https://www.statnews.comAmong their top-selling drugs, 76% of Pfizer's and 89% of J&J's were developed by other companies and account for nearly 90% of revenues.
Continue Reading https://www.statnews.com
Join the Discussion